Publicacións en colaboración con investigadores/as de University of Copenhagen (78)

2024

  1. Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies

    Joint Bone Spine, Vol. 91, Núm. 2

  2. Urease-powered nanobots for radionuclide bladder cancer therapy

    Nature Nanotechnology, Vol. 19, Núm. 4, pp. 554-564

2023

  1. Mapping the neuroanatomical abnormalities in a phenotype of male compulsive rats

    Behavioral and Brain Functions, Vol. 19, Núm. 1

  2. Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 7, pp. 1268-1275

2022

  1. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

    Kidney International, Vol. 101, Núm. 1, pp. 174-184

  2. COVID-19–related personal product shortages are associated with psychological distress in people living with gastrointestinal disorders: A cross-sectional survey

    Neurogastroenterology and Motility, Vol. 34, Núm. 3

  3. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

    Annals of the rheumatic diseases, Vol. 81, Núm. 6, pp. 768-779

  4. European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response

    Rheumatology (Oxford, England), Vol. 61, Núm. 9, pp. 3799-3807

  5. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  6. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  7. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  8. Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

    Arthritis Care and Research, Vol. 74, Núm. 7, pp. 1205-1218

  9. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

  10. The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis

    Rheumatology (Oxford, England), Vol. 61, Núm. 12, pp. 4741-4751

2021

  1. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 10, pp. 1278-1285

  2. Application and perspectives of maldi–tof mass spectrometry in clinical microbiology laboratories

    Microorganisms, Vol. 9, Núm. 7

  3. Association of Rare CYP39A1 Variants with Exfoliation Syndrome Involving the Anterior Chamber of the Eye

    JAMA - Journal of the American Medical Association, Vol. 325, Núm. 8, pp. 753-764

  4. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543

  5. EMBRACE-WATERS statement: Recommendations for reporting of studies on antimicrobial resistance in wastewater and related aquatic environments

    One Health, Vol. 13

  6. Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 11, pp. 1410-1418